INTRODUCTION
The habenular complex is divided into the lateral (LHb) and the medial portion (MHb) (Hikosaka, 2010) (Figures 1A and 1B) , and, by linking the limbic forebrain and the midbrain-extrapyramidal motor system, it regulates physiological and pathological behaviors (Sandyk, 1991) . Whereas the functions of the LHb have been the focus of intense research (Geisler and Trimble, 2008; Hikosaka, 2010) , less is known regarding the roles of the MHb (Viswanath et al., 2013) . Recent studies, however, revealed that the MHb modulates locomotion and emotional responses (Agetsuma et al., 2010; Hsu et al., 2014; Kobayashi et al., 2013; Yamaguchi et al., 2013) . The main target of MHb neurons is the mesencephalic interpeduncular nucleus (IPN) (Contestabile et al., 1987) (Figure 1B) . Selective modulation of this circuit in zebrafish impacts on aversive responses (Agetsuma et al., 2010) . However, whether similar functions exist in the mammalian brain is unknown.
Choline acetyl transferase (ChAT)-containing MHb neurons (Contestabile et al., 1987) can corelease both acetylcholine and glutamate onto target IPN neurons (Hu et al., 2012; Ren et al., 2011) . Nevertheless, the behavioral implications of this corelease have not been investigated yet.
The CB 1 R are present in habenula neurons, but their subregional location and their functions are unknown (Marsicano and Kuner, 2008; Marsicano and Lutz, 1999; Matsuda et al., 1993) . CB 1 R and their endogenous ligands form the endocannabinoid system (ECS) (Piomelli, 2003) , which, at synaptic level, retrogradely decreases the release of several neurotransmitters (Castillo et al., 2012; Degroot et al., 2006; Kano et al., 2009; Marsicano and Lutz, 2006) . Many functions of the MHb, such as the regulation of aversive memories, are also under the control of the ECS (Busquets-Garcia et al., 2015; Marsicano et al., 2002; Morena and Campolongo, 2014; Riebe et al., 2012) . This suggests that a control of the activity of the MHb-to-IPN circuit by presynaptic CB 1 R might regulate aversive memories.
In this study, we analyzed whether CB 1 R in MHb neurons (hereafter called MHb-CB 1 R) regulate aversive responses. The results reveal that endocannabinoid control of MHb-to-IPN cholinergic, but not glutamatergic, neurotransmission exerts a necessary role in the expression of aversive memories.
RESULTS
Specific Deletion of the CB 1 Gene in the MHb CB 1 R are widely expressed in different brain regions (Herkenham et al., 1990; Marsicano and Kuner, 2008) , including the habenula (Marsicano and Lutz, 1999; Matsuda et al., 1993) . However, the exact localization of habenular CB 1 R mRNA was not addressed. By fluorescent in situ hybridization (FISH), we found that CB 1 R mRNA is present in the MHb and in the adjacent paraventricular thalamic nucleus (PVT), whereas no expression was observed in the LHb ( Figure 1A and see Figure S1A available online). Consistently, immunohistochemical and tracing experiments showed that presynaptic CB 1 R protein is present in the target region of MHb neurons, the IPN ( Figures 1B, 1C , and S1B).
Considering the importance of CB 1 R and MHb in the regulation of aversive responses (Agetsuma et al., 2010; Hsu et al., 2014; Kobayashi et al., 2013; Marsicano et al., 2002; Morena and Campolongo, 2014; Riebe et al., 2012; Viswanath et al., 2013) , we addressed the specific role of CB 1 R in this brain nucleus using conditional mutagenesis. We injected adeno-associated viruses expressing Cre recombinase (AAVCre) (Soria-Gó mez et al., 2014a) directly into the MHb of CB 1 -floxed mice (Marsicano et al., 2003) to obtain MHb-CB 1 -KO mice, lacking CB 1 R expression in MHb neurons. Figure 1D shows the expression of CB 1 R mRNA in control mice injected with empty AAV vectors (MHb-CB 1 -WT mice) and in MHb-CB 1 -KO littermates. MHb-CB 1 -KO mice presented a deletion of CB 1 R mRNA in the MHb (Figures 1D and S1A Figure S1 .
ble S2), but not in adjacent areas (e.g., PVT; Figures 1D and S1A; Table S2 ).
Role of MHb-CB 1 R in Aversive Conditioning MHb-CB 1 -KO mice displayed a strongly reduced freezing response in cued and contextual fear conditioning experiments as compared to MHb-CB 1 -WT littermates (Figures 2A-2D ; Table S1 ). Importantly, the mutation did not affect potentially confounding related behaviors, such as pain (shock) sensitivity, unconditioned freezing, locomotion, and anxiety-like behavior (Figures S2A-S2J ; Table S2 ).
To test whether this function of MHb-CB 1 R extends to other aversive memory tasks, we evaluated conditioned odor aversion (COA) (Chapuis et al., 2007; Desgranges et al., 2009) . Whereas MHb-CB 1 -WT mice displayed a clear odor aversion, MHb-CB 1 -KO littermates failed to express COA ( Figure 2E ; Table  S1 ). Control analyses revealed that liquid ingestion, odor perception, and neophobia were not affected by the mutation (Figure S2K ; Table S2 ).
MHb-CB 1 -KO mice did not display any alteration in a sucrose-conditioned odor preference task (appetitive memory; Pinhas et al., 2012;  Figure S2L ; Table S2 ). In addition, the same mice displayed normal novel object recognition memory (''neutral'' memory; Puighermanal et al., 2009; Figures S2M and S2N ; Table S2 ), while maintaining the expected phenotype in a fear-conditioning test ( Figure S2O ; Table S2 ). Finally, MHb-CB 1 R deletion did not alter sucrose preference ( Figure S2P ; Table S2).
Thus, MHb-CB 1 R signaling is necessary for aversive conditioning based on different sensory modalities, but they are dispensable for appetitive or ''neutral'' memory and sucrose preference.
MHb-CB 1 R in the IPN Control the Expression of Conditioned Freezing
The main mechanism of action of the ECS in the brain is the negative control of presynaptic neurotransmitter release (Castillo et al., 2012; Degroot et al., 2006; Kano et al., 2009; Marsicano and Lutz, 2006; Piomelli, 2003) . Thus, MHb-CB 1 R might modulate aversive memories by the presynaptic regulation of neurotransmission in the IPN.
Intra-IPN injections of the CB 1 R antagonist AM251 in wildtype C57BL/6-N mice before retrieval of cued fear memory produced a dose-dependent reduction of freezing to levels very similar to the ones of MHb-CB 1 -KO mice ( Figures 3A, 3B , S3A, and S3B; Tables S1 and S2), indicating that presynaptic MHb-CB 1 R acutely control expression of aversive memories in the IPN. and MHb-CB 1 -KO mice (n = 10) undergoing conditioned odor aversion experiments. CS+, conditioned odor; CSÀ, neutral odor. Data, means ± SEM. *p < 0.05; **p < 0.01, ***p < 0.001. For details of statistical analyses, see Table S1 . See also Figure S2 . (Hu et al., 2012; Ren et al., 2011) . Thus, the phenotype of MHb-CB 1 -KO mice might be due to the lack of CB 1 R-dependent negative control of release, eventually leading to an excess of either or both neurotransmitters in the IPN. To address this issue, we adopted intra-IPN pharmacological approaches aimed at reducing this potential excess of neurotransmitter release (see Bellocchio et al., 2010; Soria-Gó mez et al., 2014a) . First, we performed dose-response experiments injecting the NMDA receptor antagonist MK801, the AMPA receptor antagonist NBQX, or the nicotinic receptor antagonist mecamylamine (MEC) into the IPN before retrieval test of cue-conditioned C57BL/6-N mice. Higher doses (3 mg of MK801 or MEC, 0.1 mg of NBQX, respectively) reduced conditioned freezing (Figures S3C-S3H ; Table S2 ). However, lower doses (1 mg of MK801 or MEC, and 0.05 mg of NBQX, respectively) were devoid of any effect (Figures S3C-S3H ; Table S2 ), and were chosen as ''subeffective'' doses for further experiments. The intra-IPN injection of 1 mg MK801 or 0.05 mg NBQX before retrieval test did not alter tone-induced freezing of either conditioned MHb-CB 1 -WT or MHb-CB 1 -KO mice (Figures 3C-3F ; Table S1 ). Conversely, intra-IPN infusion of 1 mg MEC had no effect on MHb-CB 1 -WT controls, but it fully rescued the freezing behavior of the mutants (Figures 3G and 3H ; Table  S1 ), without altering locomotion (Figures S3I-S3K ; Table S2 ) or unconditioned freezing before tone presentation ( Figure 3G) . Furthermore, the same treatment with MEC before COA test also rescued the conditioned aversion of MHb-CB 1 -KO mice ( Figure 3I ; Table S1 ).
These data indicate that CB 1 R-dependent control of cholinergic, but not glutamatergic, neurotransmission in the MHb-to-IPN circuit mediates the expression of aversive memories, independently of the sensory modalities involved.
CB 1 R in the IPN Selectively Control Cholinergic Transmission Cholinergic/glutamatergic afferents from ventral MHb neurons target mainly the medial part of the IPN, whereas dorsal MHb neurons express Substance P and mainly project to the lateral portions of the IPN (Eckenrode et al., 1987; Hsu et al., 2014; Ren et al., 2011) . Immunohistochemistry revealed that MHb-CB 1 R deletion increased the number of cells expressing the marker of neuronal activity c-Fos in the medial IPN, with no effect in the lateral portion (Figures S4A and S4C ; Table S2 ). Thus, MHb-CB 1 R appear to exert a specific presynaptic control of the activity of MHb cholinergic neurons in the medial IPN. To directly test this possibility, we performed electrophysiological recordings in IPN slices derived from mutant mice expressing the light-gated cation channel ChannelRhodopsin-2 (ChR2), exclusively in cholinergic neurons (ChAT-ChR2-EYFP mice; Figures S4D-S4F ), which have been used to study the MHb-to-IPN cholinergic pathway (Hu et al., 2012; Ren et al., 2011) . Lightinduced stimulation of cholinergic terminals in these slices can simultaneously evoke both acetylcholine and glutamate release onto IPN neurons (Hu et al., 2012; Ren et al., 2011 ; Figure 4 ). The application of the CB 1 R antagonist AM251 was not able to significantly alter light-evoked presynaptic glutamatergic release in the IPN (Figure 4A-4D ; Table S1 ). In contrast, the same treatment increased cholinergic neurotransmission evoked by photostimulation (Figures 4E-4H ; Table S1 ). Thus, presynaptic CB 1 R control cholinergic, but not glutamatergic, neurotransmission in the MHb-to-IPN pathway.
DISCUSSION
These data show that the expression of aversive memories is under the control of CB 1 R in MHb neurons synapsing onto IPN cells. Genetic deletion of MHb-CB 1 R and pharmacological inhibition of CB 1 R activity in the IPN both result in reduced aversive acquired responses, without altering appetitive or ''neutral'' memories. Thus, the ECS specifically controls the MHb-to-IPN circuit to promote aversive memory expression. Our data indicate a specific role of MHb-CB 1 R in expression of aversive memories, but a role of these receptors in other phases of learning (e.g., acquisition or consolidation) cannot be currently excluded. However, MHb-CB 1 R are clearly necessary for the expression of acquired aversive memories under different sensory modalities. This physiological function of CB 1 R is surprising, because large evidence indicates that the global genetic deletion or systemic pharmacological blockade of CB 1 R during aversive memory retrieval generally results in increased expression (or decreased extinction) of conditioned freezing (Busquets-Garcia et al., 2015; Marsicano et al., 2002; Morena and Campolongo, 2014; Riebe et al., 2012) . Thus, the present data reveal potentially opposite consequences of general endocannabinoid actions as compared to their regulation of specific circuits. Interestingly, other recent studies revealed that the functions of CB 1 R depend on the cell type(s) and the circuit(s) on which they are activated (Busquets-Garcia et al., 2015) . For instance, despite a general hyperphagic role of the ECS (Bellocchio et al., 2010; Di Marzo et al., 2001) , certain populations of CB 1 R in specific neuronal types and/or in specific circuits exert opposite functions, either promoting or inhibiting food intake (Bellocchio et al., 2010; Busquets-Garcia et al., 2015; Soria-Gó mez et al., 2014a , 2014b . The present data suggest that, in front of a general inhibitory function of the ECS on the expression of aversive memories (Busquets-Garcia et al., 2015; Marsicano et al., 2002; Morena and Campolongo, 2014; Riebe et al., 2012) , MHb-CB 1 R exert the opposite promoting function. This ''polymodal'' regulation of behavior by CB 1 R represents an example of the emerging self-regulatory and fine-tuned control of brain processes.
From the mechanistic point of view, our data consistently indicate that MHb-CB 1 R mediate the expression of aversive memories via selective presynaptic modulation of cholinergic, but not glutamatergic transmission in the IPN. The behavioral phenotypes of MHb-CB 1 -KO mice are fully rescued by partial inhibition of nicotinic receptors in the IPN, but not by the same approach targeting NMDA or AMPA glutamate receptors. Considering the impact of CB 1 R on glutamatergic transmission in other brain regions (Busquets-Garcia et al., 2015) , it is still possible that MHb-CB 1 R control other behaviors by modulating glutamate release in the IPN. Consistent with the behavioral results, modulation of IPN acetylcholine, but not of glutamate neurotransmission, is under the control of CB 1 R in electrophysiological settings. Corelease of glutamate by neurons that were generally thought to use only modulatory neurotransmitters such as acetylcholine, serotonin, or dopamine has been recently . MHb-CB 1 -WT VEH, n = 6; MHb-CB 1 -WT MK801, n = 8; MHb-CB 1 -KO VEH, n = 11; MHb-CB 1 -KO MK801, n = 8. (E and F) Time course (E) and total (F) freezing responses of MHb-CB 1 -WT and MHb-CB 1 -KO mice undergoing cued fear conditioning after pretest intra-IPN infusion of vehicle (VEH) or the AMPA receptor antagonist NBQX (0.05 mg). MHb-CB 1 -WT VEH, n = 6; MHb-CB 1 -WT NBQX, n = 6; MHb-CB 1 -KO VEH, n = 6; MHb-CB 1 -KO NBQX, n = 9. (G and H) Time course (G) and total (H) freezing responses of MHb-CB 1 -WT and MHb-CB 1 -KO mice undergoing cued fear conditioning after pretest intra-IPN infusion of vehicle (VEH) or the nicotinic receptor antagonist mecamylamine (MEC, 1 mg). MHb-CB 1 -WT VEH, n = 10; MHb-CB 1 -WT MEC, n = 6; MHb-CB 1 -KO VEH, n = 11; MHb-CB 1 -KO MEC, n = 9. (I) Odorized water intakes of MHb-CB 1 -WT and MHb-CB 1 -KO mice undergoing conditioned odor aversion (n = 7-13 per group) after pretest intra-IPN infusion of VEH or MEC (1 mg). CS+, conditioned odor; CSÀ, neutral odor. Data, means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. For details of statistical analyses, see Table  S1 . See also Figure S3 . demonstrated (Ren et al., 2011; Stuber et al., 2010; Tecuapetla et al., 2010; Varga et al., 2009 ) and could involve specific anatomical microdomains in single axons (Zhang et al., 2015) . The present data provide an example of the behavioral relevance of these unconventional synaptic events. Similar to our results, recent data show that CB 1 R activity can determine the identity of the neuromodulators used by single hypothalamic neurons (Koch et al., 2015) . However, the mechanistic explanation of this neurotransmitter-specific regulation is not currently known. Frequency-dependent neuronal activity could determine cellular functions of MHb-CB 1 R, as previously shown in GABAergic hippocampal neurons (Fö ldy et al., 2006) .
Presynaptic control of cholinergic transmission by MHb-CB 1 R is consistent with the location of CB 1 R mRNA in the ventral part of MHb and of CB 1 R protein in the medial part of the IPN, known to receive cholinergic MHb inputs (Eckenrode et al., 1987; Hsu et al., 2014; Ren et al., 2011) . CB 1 R are also present in the dorsal part of the MHb and at its main target region, the lateral portion of IPN. Nevertheless, our data clearly suggest that this subpopulation of dorsal MHb-CB 1 R does not participate in the expression of aversive memories. Previous studies showed that afferents to the dorsal or ventral parts of the MHb differentially regulate immediate postshock freezing, in apparent contradiction to our present results (Yamaguchi et al., 2013) . However, by focusing on the CB 1 R-dependent presynaptic control of efferent MHb projections onto long-term fear memory expression, our study addressed different aspects. As dorsal and ventral MHb afferents and efferents also likely contain presynaptic CB 1 R, however, their specific behavioral role(s) will be an interesting issue for future studies. (H) Normalized data of the effect of AM251 on cholinergic EPSCs (same cells as in G). ***p < 0.001; **p < 0.01; *p < 0.05; n.s., not significant. For details of statistical analyses, see Table S1 . See also Figure S4 .
The present data are also in agreement with the known ability of the ECS to modulate cholinergic transmission in other brain regions (Degroot et al., 2006) . In particular, our data clearly indicate a presynaptic control of cholinergic release at MHb-to-IPN synapses by MHb-CB 1 R during expression of aversive memories. Nicotinic receptors play a key role in these mechanisms, but the exact cellular targets of acetylcholine in this context are still to be determined. Indeed, nicotinic receptors are present at postsynaptic sites in the IPN, but also likely at presynaptic level (autoreceptors) or even on glial cells (Covernton and Lester, 2002; Liu et al., 2015) . Thus, it will be interesting to address the ''post-release'' mechanisms linking CB 1 R-dependent control of cholinergic transmission in the IPN to the expression of aversive memories.
Altogether, this study shows that CB 1 receptors control the expression of aversive memories trough the modulation of MHb-to-IPN cholinergic, but not glutamatergic, neurotransmission. Both the MHb and the ECS have been implicated in the pathogenesis of diseases linked to emotional processing such as depression, anxiety disorders or drug addiction (Hsu et al., 2014; Morena and Campolongo, 2014; Sandyk, 1991) . Considering that the control of aversive memories is an integral part of these disorders, the present data suggest that MHb-CB 1 R might represent a potential therapeutic target to tackle important brain diseases.
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